feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data",https://benzinga.com/general/biotech/21/11/23977692/the-daily-biotech-pulse-double-dose-of-positive-tidings-for-merck-alkermes-slips-on-partial-termi,https://j.mp/3BXgT4w
Benzinga,Fluidigm Q3 Sales Trail Estimates; Cuts Annual Guidance As COVID-19 Sales Retreat,https://benzinga.com/news/earnings/21/11/23976728/fluidigm-q3-sales-trail-estimates-cuts-annual-guidance-as-covid-19-sales-retreat,https://j.mp/3BYQMtU
